<DOC>
	<DOCNO>NCT02180737</DOCNO>
	<brief_summary>Evaluation role dexmedetomidine sole agent sedate patient undergoing interventional radiological procedure measure different outcome variable .</brief_summary>
	<brief_title>Dexmedetomidine Sedation During Radiological Interventional Procedures</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Age 1865 year old ASA physical status III Expected procedure last least 30 minute Unstable cardiac status ( lifethreatening arrhythmias , abnormal cardiac anatomy , significant cardiac dysfunction thirddegree heart block . An alpha2agonist antagonist within 14 day schedule procedure . patient receive IV opioid within 1 h , oral IM opioid within 4 h start study drug administration . Patients allergic Dexmedetomidine alpha 2agonists .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>dexmedetomedine</keyword>
	<keyword>sedation</keyword>
	<keyword>interventional radiology</keyword>
</DOC>